Enliven Therapeutics Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

18.05

-0.60 (-3.22%)

At close: Apr 30, 2025, 9:49 AM

Enliven Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Cash & Equivalents	124.12M	100.62M	96.87M	149.22M	100.19M	73.85M	125.72M	292.1M	88.2M	86.16M	30.43M	36.48M	110.02M	75.3M	48.04M	53.44M	47.7M	34.16M	54.65M	86.72M	4.94M
Short-Term Investments	189.32M	191.21M	215.52M	171.34M	153.01M	189.63M	152.15M	n/a	n/a	6.81M	29.91M	36.42M	41.97M	27.54M	18.73M	22.15M	40.52M	61.93M	51.62M	19.14M	23.97M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	54K	54K	54K	n/a	n/a	175K	175K	41.97M	175K	175K	88K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	7.17M	7.8M	8.13M	4.65M	4.65M	4.18M	3.93M	3.4M	807K	1.01M	-1	-1	-40.26M	n/a	n/a	220K	88K	88K	324K	88K	2.23M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.69M	5.16M	5.74M	10.05M	13M	5.13M	5.31M	5.9M	1.44M	n/a	3.92M	5.63M	n/a	3.16M	4.59M	4.77M	2.18M	3.62M	4.32M	3.95M	1.72M
Total Current Assets	318.13M	297M	318.13M	337.2M	266.15M	268.61M	283.18M	298M	89.64M	88.23M	64.26M	78.53M	110.67M	106M	71.36M	80.36M	90.41M	99.71M	110.59M	109.82M	30.62M
Property-Plant & Equipment	458K	630K	791K	924K	1.06M	1.2M	1.34M	1.4M	1.52M	1.55M	235K	2.9M	954K	855K	936K	1.02M	349K	376K	400K	418K	442K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.63M	8.43M	8.92M	5.58M	5.72M	5.43M	5.33M	4.86M	2.32M	2.57M	410K	3.07M	2.66M	1.03M	1.11M	1.33M	437K	464K	724K	506K	2.67M
Total Assets	325.76M	305.43M	327.04M	342.78M	271.87M	274.04M	288.5M	302.87M	91.96M	90.8M	64.67M	81.6M	113.33M	107.03M	72.47M	81.69M	90.84M	100.17M	111.32M	110.32M	33.3M
Account Payables	1.34M	1.02M	1.08M	2.73M	532K	1.49M	2.84M	5.86M	3.44M	2.99M	1.14M	1.88M	2.52M	2.48M	2.63M	3M	1.97M	1.89M	1.67M	2.32M	1.66M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	9.89M	5.63M	n/a	-323K	n/a	n/a	n/a	2.7M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	445K	508K	n/a	250K	254K	257K	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	4.81M	15.92M	9.49M	20.24M	21.7M	368K	4.2M	3.72M	1.64M	1.08M	1.05M	3.7M	233K	2.9M	3M	1.58M	3.19M	2.19M	1.87M	2.23M	2.54M
Total Current Liabilities	15.91M	17.03M	22.11M	25.03M	25.89M	12.08M	9.15M	10.94M	1.83M	8.33M	3.3M	7.22M	5.75M	7.19M	6.97M	5.5M	6.25M	5.31M	4.85M	4.95M	4.2M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	466K	528K	590K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	6K	34K	67K	214K	360K	508K	150.41M	150.56M	1.58M	-1	150.46M	-466K	-528K	-590K	160K	167K	n/a	179K	184K
Total Long-Term Liabilities	n/a	n/a	6K	34K	67K	214K	360K	508K	150.41M	150.56M	1.58M	1.97M	150.46M	466K	528K	590K	160K	167K	173K	179K	184K
Total Liabilities	15.91M	17.03M	22.11M	25.07M	25.96M	12.29M	9.51M	11.45M	1.83M	158.89M	3.3M	9.19M	156.22M	7.65M	7.5M	6.09M	6.41M	5.48M	5.02M	5.13M	4.38M
Total Debt	n/a	85K	169K	252K	335K	332K	329K	326K	323K	320K	445K	2.48M	159K	716K	782K	847K	n/a	n/a	n/a	n/a	n/a
Common Stock	49K	47K	47K	47K	41K	41K	41K	41K	27K	1K	27K	27K	1K	27K	19K	18K	18K	18K	18K	17K	10K
Retained Earnings	-243.47M	-220.29M	-197.14M	-177.19M	-154.45M	-135.08M	-114.31M	-97.59M	-146.01M	-73.31M	-173.59M	-162.14M	-45.2M	-133.18M	-119.53M	-106.37M	-96.11M	-84.59M	-72.17M	-61.97M	-54.75M
Comprehensive Income	55K	242K	-139K	-53K	141K	-147K	-111K	-0.00	-176.75K	-4K	-35K	-51K	-16K	-2K	n/a	1K	4K	24K	48K	-16K	32K
Shareholders Equity	309.85M	288.4M	304.93M	317.71M	245.91M	261.75M	278.99M	291.42M	90.13M	-68.1M	61.36M	72.41M	-42.89M	99.37M	64.97M	75.59M	84.44M	94.7M	106.3M	105.19M	28.92M
Total Investments	189.32M	191.21M	215.52M	171.34M	153.01M	189.63M	152.15M	54K	n/a	6.81M	30.08M	36.59M	41.97M	27.72M	18.91M	22.24M	40.52M	61.93M	51.62M	19.14M	23.97M